Abstract
This document provides requirements and guidelines on the development of drug delivery systems intended for self-administration of medicinal products by the specific demographic group of paediatric patients who are performing some or all use steps required for their intended use.
Use steps include any handling action performed after the patient has received the product; these can include but are not limited to:
—ÌýÌýÌýÌý transport – carrying the product while travelling (e.g. by walking, train, airplane, automobile, bus);
—ÌýÌýÌýÌý storage – storage by the patient in their home, school, office or in temporary storage cases before or between uses;
—ÌýÌýÌýÌý preparation – steps necessary to place the product in a state where it is ready to be administered;
—ÌýÌýÌýÌý operation – steps necessary to initiate, adjust, pause, stop, or otherwise manage the delivery of medication using the product;
—ÌýÌýÌýÌý maintenance – steps necessary to keep the product in good working order;
—ÌýÌýÌýÌý disposal – steps to ensure safe disposal of the product after use (e.g. placement of the product in a suitable receptacle).
This document is applicable to injectable drug delivery systems for administration of medicinal products. Furthermore, this document can be useful for the development of other drug delivery devices or systems if they are intended for use by the paediatric population. Devices not in the scope of this document include catheters, for example those in the scope of Ïã¸ÛÁùºÏ²Ê¿ª½±Â 10555 series, and infusion pump systems, e.g. IEC 60601-2-24 and aerosol delivery devices (Ïã¸ÛÁùºÏ²Ê¿ª½±Â 20072).
General information
-
Status: PublishedPublication date: 2024-02Stage: International Standard published [60.60]
-
Edition: 1Number of pages: 39
-
Technical Committee :Ïã¸ÛÁùºÏ²Ê¿ª½±/TC 84ICS :11.040.25
- RSS updates
Life cycle
Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)